Feasibility Study of Intraperitoneal Paclitaxel With Oxaliplatin and Capecitabine in Patients With Advanced Gastric Cancer
Phase of Trial: Phase II
Latest Information Update: 16 Jun 2016
At a glance
- Drugs Paclitaxel (Primary) ; Capecitabine; Oxaliplatin
- Indications Gastric cancer
- Focus Therapeutic Use
- 06 Jun 2016 Planned End Date changed from 1 Nov 2015 to 1 Aug 2018.
- 08 Jan 2013 New trial record
- 01 Jan 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.